Diarrhea is one of the most common side effects of GLP-1 medications. In the clinical trials behind the two main weight loss drugs, somewhere between 19% and 30% of people on active treatment had it, compared with 8% to 16% on placebo.12 For most people it shows up during the first weeks or after a dose change and then settles. The symptoms below tell you when to ride it out and when to call.
The Quick Answer
GLP-1 diarrhea is a gastrointestinal side effect that tends to cluster around dose increases. In the semaglutide trials, 30% of adults had diarrhea versus 16% on placebo, and in the tirzepatide trials, 19% to 23% of people on tirzepatide had it versus 8% on placebo.12 Eating smaller, lower-fat meals and keeping up fluids may help. Diarrhea that is severe, bloody, or comes with dizziness or very little urine needs a call to your provider the same day.
How Common GLP-1 Diarrhea Is
Both drugs list diarrhea among their most frequent adverse reactions, and the numbers in the table come straight from the prescribing information.
| Medication | Diarrhea on drug | Diarrhea on placebo |
|---|---|---|
| Semaglutide 2.4 mg (pooled adult trials, up to 68 weeks) | 30% | 16% |
| Tirzepatide 5 mg (pooled weight-reduction trials) | 19% | 8% |
| Tirzepatide 10 mg (pooled weight-reduction trials) | 21% | 8% |
| Tirzepatide 15 mg (pooled weight-reduction trials) | 23% | 8% |
Sources: the semaglutide and tirzepatide prescribing information.12 The two programs ran different trials in different populations, so the columns aren't a head-to-head comparison and shouldn't be read as one drug being gentler than the other.
Very few people stop treatment because of it. The semaglutide label reports that diarrhea led to discontinuation in 0.7% of adults on the drug versus 0.1% on placebo.1 For tirzepatide, gastrointestinal reactions as a group (nausea, vomiting, diarrhea and the rest) led to discontinuation in 1.9% to 4.3% of people on drug versus 0.5% on placebo in the pooled weight-reduction trials.2
Why GLP-1s Cause Diarrhea
GLP-1 receptors sit in the gut as well as the brain, and the medications slow how quickly food leaves your stomach. That's the same effect that makes you feel full sooner, and it's also why constipation is common on these drugs. Diarrhea is the flip side. The gut is adjusting to a new rhythm, and in some people that adjustment loosens things up instead of slowing them down. Research suggests the exact mechanism isn't fully mapped, which is part of why the same drug can cause constipation in one person and diarrhea in another, and sometimes both in the same month.
The pattern in the trials is easier to describe than the mechanism. Gastrointestinal events were most frequent during dose escalation and became less frequent over time, according to the tirzepatide data.3 That fits what clinicians see in practice: a flare after a step up in dose, then a gradual quieting.
Food matters too. Eating a large, greasy meal when your stomach empties slowly is a reliable way to end up in the bathroom, and many people on a GLP-1 are also changing what they eat, adding more protein shakes, sugar alcohols, fiber supplements, or dairy than they used to. Any one of those can contribute.
What May Help
There aren't trials that test each of these tips on GLP-1 patients, so treat the list as common clinical practice rather than proven fixes.
- Eat smaller meals, and keep the fat low when your gut is unhappy. Rich, fried, and very large meals are the usual triggers.
- Look at the sugar alcohols. Sorbitol, xylitol, and maltitol in protein bars and "sugar-free" products can cause diarrhea on their own.
- Check your protein shake. Some whey concentrates and dairy-heavy shakes upset the gut, and switching to an isolate or a different base may help.
- Drink fluids steadily through the day. Water alone may not be enough if stools are very loose, so some people add an electrolyte drink.
- Add soluble fiber slowly. Oats, bananas, and psyllium may firm things up, but a sudden jump in fiber can backfire.
- Keep a short log. Note the day of your injection, what you ate, and when symptoms hit. A pattern often shows up in two weeks.
Anti-diarrheal medicines like loperamide are sometimes used, but ask your prescriber first, particularly if you have a fever or blood in your stool. And if the diarrhea started right after a dose increase, your provider may decide to change the plan. That decision belongs to the person managing your prescription, so please don't adjust your own dose or timing. Our guide to what to eat on a GLP-1 covers the meal side in more detail.
When Diarrhea Becomes a Problem
The reason to take this seriously is dehydration. Both labels warn that GLP-1 medicines can cause volume depletion, and that in people who become dehydrated this may lead to acute kidney injury.12 Our post on whether GLP-1s are bad for your kidneys covers the numbers. The short version is that kidney trouble on these drugs is uncommon and usually tied to fluid loss from vomiting or diarrhea, which is why persistent symptoms deserve attention.
Call your provider the same day if you have:
- Diarrhea lasting more than a few days without easing
- Blood in your stool or black, tarry stools
- Dizziness, a racing heart, or feeling faint when you stand
- Very little urine, or dark urine
- Severe or constant abdominal pain, especially pain that spreads to your back, since both labels also warn about pancreatitis
- Fever with diarrhea
Diarrhea or Constipation, or Both?
Some people swing between the two, particularly in the first few months. The semaglutide label reports constipation in 24% of adults versus 11% on placebo, so it's not unusual to see loose stools one week and hard ones the next.1 If that sounds like you, our guide to GLP-1 constipation covers the other side, GLP-1 acid reflux covers heartburn, and the broader guide to managing GLP-1 side effects covers nausea and the rest.
How We Handle It at Defiant
At Defiant, the GLP-1 program starts from $295/mo and includes medical provider oversight, bi-weekly titration check-ins, monthly Styku body composition scans, and ongoing nurse access. The bi-weekly schedule gives us more frequent points to hear how your gut is handling each step, so a problem doesn't sit for a month before anyone asks about it. We serve patients from Lisle, Naperville, Downers Grove, Wheaton, and Oak Brook.
- In the trials, diarrhea affected 30% of adults on semaglutide 2.4 mg (16% on placebo) and 19% to 23% of those on tirzepatide (8% on placebo).
- Gastrointestinal side effects tend to be most frequent during dose escalation and become less frequent over time.
- Smaller, lower-fat meals, a look at sugar alcohols and shakes, and steady fluids may help.
- The main risk is dehydration, which the labels link to possible kidney injury.
- Bloody stools, dizziness, very little urine, fever, or severe belly pain mean call your provider the same day.
- Dose changes are a prescriber's call. Don't change your dose on your own.
Frequently Asked Questions
Side Effects Shouldn't Be a Solo Project.
Defiant's GLP-1 program pairs medical oversight and nurse access with bi-weekly check-ins, so questions like this get answered early. Serving Lisle, Naperville, Downers Grove, and Chicago's western suburbs.
Keep Reading
Last updated November 8, 2026.
References
- Semaglutide 2.4 mg injection prescribing information (adverse reactions: diarrhea 30% vs 16%, constipation 24% vs 11%, diarrhea discontinuation 0.7% vs 0.1%; warnings: acute kidney injury due to volume depletion, pancreatitis). Prescribing information
- Tirzepatide prescribing information (adverse reactions: diarrhea 19%/21%/23% vs 8% in pooled weight-reduction trials; GI discontinuation 1.9/3.3/4.3% vs 0.5%; warnings: acute kidney injury, pancreatitis). Prescribing information
- Eli Lilly Medical Information. Gastrointestinal adverse events reported in tirzepatide clinical studies (SURMOUNT-1): GI events most frequent during dose escalation and decreasing over time; diarrhea 19%/21%/23% at 5/10/15 mg. Lilly Medical